Additional file 1: of Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer’s disease: a network meta-analysis of 41 randomized controlled trials

Supplementary 1. Network meta-analysis model. Supplementary 2. References for included trials. Supplementary 3. Summary of included trials and patient characteristics. Supplementary 4. Risk of bias assessment. Supplementary 5. Results from pairwise meta-analysis for each outcome. Supplementary 6. Results from network meta-analysis for each outcome. Supplementary 7. Network plot for each outcome. Supplementary 8. Treatment ranking and rankograms for each outcome. Supplementary 9. Assessment of inconsistency results for each outcome. Supplementary 10. Comparison-adjusted funnel plot for each outcome from the network meta-analysis. Supplementary 11. Subgroup network meta-analysis for secondary outcomes. Supplementary 12. Sensitivity network meta-analysis for primary outcomes. Supplementary 13. Assessment of heterogeneity results for each outcome. (PDF 2427 kb